Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New developments in fetal and neonatal alloimmune thrombocytopenia.

American journal of obstetrics and gynecology - 1 Aug 2021

Bussel James B, Vander Haar Emilie L, Berkowitz Richard L

Abstract excerpt

Fetal and neonatal alloimmune thrombocytopenia, the platelet equivalent of hemolytic disease of the fetus and newborn, can have devastating effects on both the fetus and neonate. Current management of fetal and neonatal alloimmune thrombocytopenia in a subsequent affected pregnancy involves antenatal administration of intravenous immune globulin and prednisone to the pregnant woman to prevent the development of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Human Platelet
Share to Drug Development
Share to Immunoglobulins, Intravenous

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunologic Factors

Share to Integrin beta3

Share to Maternal-Fetal Exchange

Share to Prednisone

Share to Receptors, Fc

Source

Identifiers

PMID: 33839095
DOI: 10.1016/j.ajog.2021.04.211

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New developments in fetal and neonatal alloimmune thrombocytopenia.PMID 33839095Read ↗

Fetal thrombocytopenia.Semantic proximity Read ↗

Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and managementSemantic proximity Read ↗

Determination of human platelet antigen typing by molecular methods: Importance in diagnosis and early treatment of neonatal alloimmune thrombocytopenia.Semantic proximity Read ↗

Antenatal management of fetal and neonatal alloimmune thrombocytopenia: Integration of clinical history and maternal HLA-DRB3*01:01 genotyping in clinical decision-making.Semantic proximity Read ↗

Neonatal alloimmune thrombocytopenia: current considerations.Semantic proximity Read ↗

Fetal and neonatal alloimmune thrombocytopenia: Current pathophysiological insights and perspectives for future diagnostics and treatmentSemantic proximity Read ↗

Treatment Options for the Fetus With Alloimmune Hemolytic DiseaseSemantic proximity Read ↗

Neonatal alloimmune thrombocytopaenia associated with maternal HLA antibodies.Semantic proximity Read ↗

Noninvasive Prenatal Testing in Immunohematology—Clinical, Technical and Ethical ConsiderationsSemantic proximity Read ↗

Prenatal testing for hemolytic disease of the newborn and fetal neonatal alloimmune thrombocytopenia - current status.Semantic proximity Read ↗

Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a.Semantic proximity Read ↗

The prenatal identification of fetal compatibility in neonatal alloimmune thrombocytopenia using amniotic fluid and variable number of tandem repeat (VNTR) analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.